Schwartz Aharon — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Schwartz Aharon is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $206K.
Profile
Aharon Schwartz is a corporate executive known for his role in the biotechnology sector, particularly with Protalix BioTherapeutics, Inc., a biopharmaceutical company focused on developing and commercializing protein therapies based on its proprietary ProCellEx platform. His contributions to the company have been significant in advancing its therapeutic pipeline and strategic initiatives.
Role
Insider
Notability
65/100
Board memberships
Protalix BioTherapeutics, Inc.
Awards & honors
Leadership in biopharmaceutical development
Contributions to Protalix's therapeutic advancements
Aharon Schwartz is a corporate executive known for his role in the biotechnology sector, particularly with Protalix BioTherapeutics, Inc., a biopharmaceutical company focused on developing and commercializing protein therapies based on its proprietary ProCellEx platform. His contributions to the company have been significant in advancing its therapeutic pipeline and strategic i…
Has Schwartz Aharon been buying or selling stock?
Recorded transactions: 1 open-market purchases ($206K) and 0 open-market sales () across all tracked filings.
Where can I see all of Schwartz Aharon's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
